C07D 215/36
Sulfur atoms
Official title: Sulfur atoms (C07D215/24 takes precedence)
C07D215/36 (Sulfur atoms) appears on 531 US grants and 417 published applications in this corpus.
Search patents in C07D- Granted patents
- 531
- Published applications
- 417
- Assignees
- 321
- Inventors
- 1,858
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 3 | 0 |
| 1978 | 4 | 0 |
| 1979 | 3 | 0 |
| 1980 | 3 | 0 |
| 1981 | 1 | 0 |
| 1982 | 3 | 0 |
| 1983 | 4 | 0 |
| 1984 | 7 | 0 |
| 1985 | 2 | 0 |
| 1986 | 3 | 0 |
| 1987 | 6 | 0 |
| 1988 | 12 | 0 |
| 1989 | 4 | 0 |
| 1990 | 7 | 0 |
| 1991 | 8 | 0 |
| 1992 | 13 | 0 |
| 1993 | 18 | 0 |
| 1994 | 13 | 0 |
| 1995 | 19 | 0 |
| 1996 | 15 | 0 |
| 1997 | 9 | 0 |
| 1998 | 15 | 0 |
| 1999 | 19 | 0 |
| 2000 | 11 | 0 |
| 2001 | 30 | 3 |
| 2002 | 18 | 17 |
| 2003 | 18 | 24 |
| 2004 | 17 | 38 |
| 2005 | 12 | 27 |
| 2006 | 19 | 20 |
| 2007 | 13 | 16 |
| 2008 | 11 | 17 |
| 2009 | 16 | 22 |
| 2010 | 14 | 13 |
| 2011 | 10 | 15 |
| 2012 | 11 | 13 |
| 2013 | 9 | 14 |
| 2014 | 12 | 15 |
| 2015 | 13 | 10 |
| 2016 | 6 | 10 |
| 2017 | 10 | 12 |
| 2018 | 6 | 14 |
| 2019 | 16 | 18 |
| 2020 | 14 | 20 |
| 2021 | 12 | 12 |
| 2022 | 12 | 12 |
| 2023 | 6 | 22 |
| 2024 | 7 | 13 |
| 2025 | 8 | 10 |
| 2026 | 7 | 10 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods for treating muscular dystrophies22 Sep 2026US 12,741,939 B2The Regents of the University of California
- Methods and compositions for targeting Tregs using CCR8 inhibitors28 Jul 2026US 12,692,239 B2Nanjing Immunophage Biomedical Co., Ltd.
- Crystalline forms of n-(4-(4-(cyclopropylmethyl)piperazine-1-carbonyl)phenyl)quinoline-8-sulfonamide28 Apr 2026US 12,612,381 B2Agios Pharmaceuticals, Inc.
- Methods and materials for inhibiting NF-kB activity21 Apr 2026US 12,606,528 B2University of Pittsburgh—Of the Commonwealth System of Higher Education
- Tricyclic sulfones as ROR gamma modulators10 Mar 2026US 12,570,609 B2Bristol-Myers Squibb Company
- Methods and compositions for prevention of anaphylaxis20 Aug 2026US 2026/0242369 A1Baylor College of Medicine
- Therapeutic compounds and compositions13 Aug 2026US 2026/0234110 A1Agios Pharmaceuticals, Inc.
- Crystalline forms of n-(4-(4-(cyclopropylmethyl)piperazine-1-carbonyl)phenyl)quinoline-8-sulfonamide30 Jul 2026US 2026/0217676 A1Agios Pharmaceuticals, Inc.
- Compounds and compositions for treating conditions associated with nlrp activity16 Jul 2026US 2026/0200880 A1Novartis AG
- Tricyclic sulfones as ror gamma modulators25 Jun 2026US 2026/0176237 A1
Most cited
By later US patents
- Quinoline and quinazoline derivatives inhibiting platelet-derived growth factor receptor autophosphorylation and pharmaceutical compositions containing the same156US 6,143,764 AKirin Beer Kabushiki Kaisha · 2000
- Nitrogen-containing aromatic derivatives135US 7,253,286 B2Eisai Co., Ltd. · 2007
- Chemical compounds as inhibitors of amyloid beta protein production110US 5,624,937 AEli Lilly and Company · 1997
- Quinoline sulfonamides and their therapeutic use110US 5,834,485 AChiroscience Limited · 1998
- IL-8 receptor antagonists92US 5,886,044 ASmithKline Beecham Corporation · 1999